Ensysce Biosciences, Inc.

ENSCNASDAQHealthcare● Active

$0.25

$-0.00(-0.43%)

Market Cap$2347288

P/E Ratio—

52W High$2.75

52W Low$0.23

Avg Volume2.2M

Open$0.26

Beta0.84

Net Income Financials Revenue

Ensysce Biosciences, Inc. (ENSC) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

ENSC · net income · updated Jun 8, 2026

Core profitability metrics

ENSC · net income · margin · TTM · CAGR

Net income was −$10.2M for FY2025 (fiscal year ending 2025-12-31), down 27.4% year-over-year. Net profit margin was -200.8%. Based on available data, Ensysce Biosciences, Inc. has been profitable since at least 2020.

FY2025 Net Income−$10.2M▼ -27.4% YoY

Trailing 12M (TTM)−$11.8Mtrailing 4 quarters sum

Net Profit Margin-200.8%−$10.2M ÷ $5.1M

YoY Change-27.4%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2020

▸ FMP /income-statement · Annual · ENSC net income history · ENSC profit margin

Annual net income data

ENSC · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$10.2M▼ 27.4%-200.8%$5.1M

FY2024Loss−$8.0M▲ +24.7%-153.3%$5.2M

FY2023Loss−$10.6M▲ +56.1%-475.7%$2.2M

FY2022Loss−$24.2M▲ +16.9%-957.9%$2.5M

FY2021Loss−$29.1M▼ 51330.8%-823.6%$3.5M

Net income vs peers (Healthcare)

ENSC vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Ensysce Biosciences, Inc.YOU

ENSC

−$10.2M-27.4%-200.8%

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Ensysce Biosciences, Inc. (ENSC) reported net income of −$10.2M for FY2025 (fiscal year ending 2025-12-31), down 27.4% year-over-year. The net profit margin was -200.8% — meaning the company kept $-2.01 of every dollar of revenue as profit.

Based on available data, Ensysce Biosciences, Inc. has been profitable since at least 2020. Net income reached a peak of $56,770 in FY2020. Data available for 9 fiscal years.

Ensysce Biosciences, Inc.'s net profit margin was -200.8% for FY2025, based on the latest annual results.

Investors sometimes search for "Ensysce Biosciences, Inc. net worth" — the company's market capitalization is a separate figure from ENSC net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

ENSC net income · 4 questions

Ensysce Biosciences, Inc. is not currently profitable on an annual basis. The company reported a net loss of $10.2M for FY2025.

is ENSC profitabledoes ENSC make a profitENSC profitabilityENSC profitable company

▸ Source: FMP /income-statement · GAAP · Ensysce Biosciences, Inc. · Ensysce Biosciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026